Nocardia asteroides
Nocardia asteroides is a species of bacteria belonging to the genus Nocardia. It is a Gram-positive, aerobic, non-motile bacterium that is known for causing Nocardiosis, a rare infectious disease that primarily affects the lungs but can also impact the brain and skin.
Taxonomy
The bacterium was first described in 1888 by French veterinarian and microbiologist Edmond Nocard. It belongs to the family Nocardiaceae, within the order Actinomycetales. The genus Nocardia is named after its discoverer, and the species name 'asteroides' refers to its star-like appearance under the microscope.
Morphology
Nocardia asteroides is a rod-shaped bacterium that forms branching filaments, similar to fungi. It is Gram-positive, meaning it retains the violet stain used in the Gram stain procedure. The bacterium is also aerobic, requiring oxygen for growth, and is non-motile, lacking the structures needed for self-propulsion.
Pathogenicity
Nocardia asteroides is the most common cause of Nocardiosis, a rare infection that can affect both humans and animals. The bacterium is typically found in soil and enters the body through inhalation or through open wounds. Once inside, it can cause a variety of symptoms, ranging from pulmonary infections to brain abscesses and skin lesions. The disease is most common in individuals with weakened immune systems, such as those with HIV/AIDS or those undergoing immunosuppressive therapy.
Treatment
Treatment for Nocardiosis typically involves long-term antibiotic therapy, often with a combination of drugs such as sulfonamides, aminoglycosides, and carbapenems. In severe cases, surgical intervention may be necessary to remove abscesses or to treat extensive skin lesions.
Research
Research into Nocardia asteroides and Nocardiosis is ongoing, with scientists seeking to better understand the bacterium's pathogenicity and to develop more effective treatments. Current areas of focus include the bacterium's resistance mechanisms, its interaction with the host immune system, and the development of new diagnostic methods.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

